Raymond Prudo-Chlebosz - May 31, 2024 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Wendy F. DiCicco, as Attorney-in-Fact for Raymond Prudo-Chlebosz, M.D.
Stock symbol
AKTX
Transactions as of
May 31, 2024
Transactions value $
$2,387,264
Form type
4
Date filed
6/4/2024, 04:45 PM
Previous filing
Jan 2, 2024
Next filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $1.19M +1.33B +56.88% $0.00* 3.66B May 31, 2024 Direct F1, F2
holding AKTX Ordinary Shares, par value $0.0001 per share 38.7M May 31, 2024 Praxis Trustees Limited F1
holding AKTX Ordinary Shares, par value $0.0001 per share 801M May 31, 2024 RPC Pharma Limited F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKTX Warrants (Right to Buy) Award $1.19M +1.33B $0.00* 1.33B May 31, 2024 Ordinary Shares, par value $0.0001 per share 1.33B $0.00 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
F2 On May 31, 2024, the Reporting Person acquired 1,326,258,000 Ordinary Shares and accompanying warrants to purchase up to 1,326,258,000 Ordinary Shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of May 29, 2024. The combined purchase price was $0.0009425 per Ordinary Share and accompanying warrant.
F3 The warrants have an exercise price of $0.000895 per Ordinary Share.

Remarks:

See Exhibit 24.1 - Power of Attorney